Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Cost Effectiveness of Antimicrobial Catheters for Adults Requiring Short-term Catheterisation in Hospital

Lookup NU author(s): Professor Luke ValeORCiD, Rob Pickard

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Catheter-associated urinary tract infection (CAUTI) is the second most common cause of hospital-acquired infection. A number of strategies have been put forward to prevent CAUTI, including the use of antimicrobial catheters. We aimed to assess whether the use of either a nitrofurazone-impregnated or a silver alloy-coated catheter was cost-effective compared with standard polytetrafluoroethylene (PTFE)-coated catheters. A decision-analytic model using data from a clinical trial conducted in the United Kingdom was used to calculate the incremental cost per quality-adjusted life-year (QALY). We assumed that differences in costs and QALYs were driven by difference in risk of acquiring a CAUTI. Routine use of nitrofurazone-impregnated catheters was, on average, 7 pound ((sic)9) less costly than use of the standard catheter over 6 wk. There was a >70% chance that use of nitrofurazone catheters would be cost saving and an 84% chance that the incremental cost per QALY would be less than 30 pound 000 ((sic)36 851; a commonly used threshold for society's willingness to pay). Silver alloy-coated catheters were very unlikely to be cost-effective. The model's prediction, although associated with uncertainty, was that nitrofurazone-impregnated catheters may be cost-effective in the UK National Health System or a similar setting. (C) 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.


Publication metadata

Author(s): Kilonzo M, Vale L, Pickard R, Lam T, N'Dow J, for the Catheter Trial Group

Publication type: Article

Publication status: Published

Journal: European Urology

Year: 2014

Volume: 66

Issue: 4

Pages: 615-618

Print publication date: 01/10/2014

Online publication date: 21/06/2014

Acceptance date: 27/05/2014

ISSN (print): 0302-2838

ISSN (electronic): 1873-7560

Publisher: Elsevier BV

URL: http://dx.doi.org/10.1016/j.eururo.2014.05.035

DOI: 10.1016/j.eururo.2014.05.035


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Chief Scientist Office of the Scottish Government Health Directorates
05/46/01UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme

Share